In lung cancer, we and other groups reported that activation of HGF/MET causes resistance to EGFR‐TKIs and ALK‐TKIs in EGFR‐mutated NSCLC and ALK‐rearranged NSCLC, respectively.15, 22. This evidence concerns the gene EGFR and non-small cell lung carcinoma.